Your Sequencer Isn’t
The Bottleneck.
We Proved It at ASHG.
ASHG 2026 | October 20–24 | Montréal, Canada
ASHG 2026 confirmed what we’ve been building toward: the field is ready for AI that doesn’t just call variants but explains, traces, and scales every decision. Here’s what the conversations at Booth #1822 revealed, and what we’re doing about it.
ClairLabs in SpotLight at the AI & ML Poster Session

Authors: Amit Parhar, Raj Tulluri, Shivangi Wagh, Apurva Narayan
Presenter: Amit Parhar, Sr. Director – Strategic Sales
Venue: Wednesday, October 21, 2026, 2:30–4:30 PM EDT | Palais des Congrès de Montréal
This poster demonstrated how a multi-agent AI architecture, grounding every variant classification in traceable evidence chains, delivers clinician-ready outputs in minutes, not hours – all while maintaining full ACMG/AMP compliance and audit-trail integrity.
vs. 2–4 hours manual
in manual curation burden
accuracy
in pathogenic variant ranking
validated
patient samples
Our Platforms & Solutions
Impactomics
Our Flagship Multi-omics Platform
At ASHG 2026, genomics teams asked the same question: how do you move from raw sequence to ranked variants without fragmenting across six tools? Impactomics delivers end-to-end automated variant interpretation, phenotype-driven gene ranking, multi-omics correlation, and audit-trailed cloud pipelines – all in one governed workflow.
|
• Automated NGS variant interpretation with ACMG-aligned classification |
• Phenotype-driven gene ranking that cuts analyst review time by half |
|
• Real-time multi-omics correlation across genomic, transcriptomic, and more. |
• Scalable cloud genomics analysis pipelines with full audit trails |
ClairOS
Multi-agent AI for Variant Intelligence
The conversations at Booth #1822 converged on one demand: AI that explains its reasoning, not just its output. ClairOS orchestrates specialized agents BAM QC Expert, Literature & Database Expert, BioCompute Agent, and Supervisor Agent, delivering variant classifications that are traceable, auditable, and defensible under CAP/CLIA review.
|
• Explainable AI that traces every classification back to its source evidence |
• Human-in-the-loop review workflows designed for clinical decision support (CDS) |
|
• Compliance-ready architecture aligned with HIPAA, CLIA, and CAP standards |
|




The Team Behind Amazing ASHG Conversations
integration
Encountering business challenges that are costing
you time, accuracy, and throughput?
3 Gaps Every Lab Mentioned
| The Gap | How We Solve It |
|---|---|
Interpretation BacklogLabs generating 500+ samples per week are still curating at 2–4 hours per variant. More than the sequencer, the analyst queue is the bottleneck. |
ClairOS delivers 3–5 minutes per variant with 96% accuracy, without removing the human from the loop. |
Multi-omics FragmentationGenome, RNA-seq, methylation, and proteomics data analyzed in four separate workflows produce four separate truths. |
Impactomics orchestrates cross-modal analysis in a single governed pipeline, correlating variants across omics layers to surface what single-modality workflows miss. |
Audit Trail DebtCAP/CLIA inspectors don’t want your variant calls. They want the reasoning chain behind them. |
ClairOS produces deterministic fallback loops, immutable versioned logs, and traceable agent decision chains — so every AI-assisted classification is defensible before it reaches the clinician. |
|
Which gap is costing your lab the most? Schedule a Conversation |
|
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. Lorem ipsum dolor sit amet, consetetur sadipscing elitr. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut.
From Our Thought Leaders’ Desk
Download our latest thought leadership content

How leading clinical genomics labs are using automation and AI to cut curation time while maintaining compliance.

A deep dive into what happens after sequencing, and how AI-powered genomics is closing the gap between raw data and clinical action.

An expert analysis of the five themes that will dominate this year's agenda, from AI in variant interpretation to globally representative genomics.
Related Solutions
.jpg?width=300&name=048fe5e71d05e92b27c3f32758269d2404fe5aff%20(1).jpg)
Deploy containerized NGS workflows on cloud-native infrastructure. Automate variant calling, annotation, and reporting for high-throughput genomic diagnostics and research.
.jpg?width=300&name=048fe5e71d05e92b27c3f32758269d2404fe5aff%20(1).jpg)
Deploy containerized NGS workflows on cloud-native infrastructure. Automate variant calling, annotation, and reporting for high-throughput genomic diagnostics and research.
.jpg?width=300&name=048fe5e71d05e92b27c3f32758269d2404fe5aff%20(1).jpg)
Deploy containerized NGS workflows on cloud-native infrastructure. Automate variant calling, annotation, and reporting for high-throughput genomic diagnostics and research.